z-logo
open-access-imgOpen Access
Hepatorenal Syndrome
Author(s) -
Abdussalam Shredi,
Sakolwan Suchartlikitwong,
Hawa Edriss
Publication year - 2018
Publication title -
the southwest respiratory and critical care chronicles
Language(s) - English
Resource type - Journals
ISSN - 2325-9205
DOI - 10.12746/swrccc.v6i22.439
Subject(s) - hepatorenal syndrome , medicine , pathogenesis , cardiorenal syndrome , vasoconstriction , acute kidney injury , cardiology , kidney , cirrhosis
Hepatorenal syndrome is a form of acute kidney injury that occurs in chronic liver diseaseand acute fulminant liver failure. This syndrome features a rapid progressive decline in renalfunction in the absence of other obvious causes of renal dysfunction. The pathophysiologyof this syndrome is still not completely understood, and several mechanisms have beenproposed to explain its pathogenesis. The characteristic feature of hepatorenal syndrome isintense renal vasoconstriction. The local production of vasodilator substances as a result ofportal hypertension have a central role in the pathogenesis of the hepatorenal syndrome asthey lead to splanchnic pooling and decreased effective systemic arterial plasma volume andrenal vasoconstriction. Hepatorenal syndrome is a diagnosis of exclusion and is considered achallenging medical condition in both diagnosis and treatment as it is associated with a poorprognosis. This article will review the two main hypotheses about the pathogenesis, diagnosticcriteria, and treatment approaches to the hepatorenal syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here